机译:基于ATP响应适体的金属有机骨架纳米颗粒(NMOF),用于控制释放药物和药物
Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, Inst Chem, IL-91904 Jerusalem, Israel;
Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, Inst Chem, IL-91904 Jerusalem, Israel;
Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, Inst Chem, IL-91904 Jerusalem, Israel;
Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel;
Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, Inst Chem, IL-91904 Jerusalem, Israel;
Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, Inst Chem, IL-91904 Jerusalem, Israel;
Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel;
Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, Inst Chem, IL-91904 Jerusalem, Israel;
cytotoxicity; doxorubicin; drug release; nucleic acids; targeting;
机译:基于锆的纳米金属有机框架UiO-67-NH_2具有较高的载药量,可喜树碱的控释
机译:刺激响应的基于核酸的聚丙烯酰胺水凝胶包衣的金属有机骨架纳米粒子用于药物的控制释放。
机译:DNA响应性SiO2纳米颗粒,金属有机框架和用于受控药物释放的微胶囊
机译:具有受控药物释放的多模式上转化纳米粒子作为药物递送系统
机译:可行性研究:金属有机框架(MOF)作为异硫氰酸烯丙酯(AITC)吸附和控制释放的新型传递系统
机译:金属有机骨架涂层磁铁矿纳米颗粒用于协同磁热疗和通过pH触发药物释放的化疗
机译:药物递送:用于控制载荷和药物的受控释放的ATP响应型适体的金属 - 有机骨架纳米颗粒(ADV。Funct。Matter。37/2017)